Efficacy, Safety and Immunological Evaluation of Tofacitinib in the Treatment of Primary Sjogren's Syndrome
Condition: Primary Sjögren's Syndrome Intervention: Drug: Tofacitinib Sponsor: Peking University People's Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 21, 2021 Category: Research Source Type: clinical trials
